Scholars Central

Conference abstractPublished 12 Oct 2017

A PROSPECTIVE, OPEN LABEL, EXPERIMENTAL STUDY TO EVALUATE IF GLUCOPHAGE GIVEN ORALLY TWICE DAILY IN ADULT PATIENTS WITH PREDIABETES CAN REVERSE DIABETES AND ITS RELATED COMPLICATIONS.

Authors: Ishrat Kazmi

Product & Key Accounts Manager âÂ?Â? Diabetes, Pakistan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Prevalence of diabetes is increasing rapidly in low to middle-income countries including Pakistan, having 7 million adult diabetics, expected to rise to 14.4 million by 2040. An increase in diabetes related complications as heart attack, stroke, nerve damage, leg amputation, & vision loss. Effective approaches are available to prevent diabetes & its complications such as exercise, life-style intervention and pharmacological intervention to reverse diabetes. Our study will evaluate the preventive effects of metformin & lifestyle changes in pre-diabetics. Commercial projects: Before this study, different projects initiated such as âÂ?Â?YOUNGSTERâÂ? (Young Generation Diabetes FRee Project). This project is mainly based on creating awareness (Non-Pharmcological) about Pre-Diabetes among the young generation. Methods: Afterwards, we initiated an open label, prospective, experimental study âÂ?Â?PREVENTâÂ? (Prevent and REduce Diabetes & cardioVascular Events by MetformiN Treatment) in adult patients having HbA1c ranging from 5.7 to 6.4. The study will enroll 692 patients, with a dropout rate of 15% having 4 arms, control group, metformin group, lifestyle group and metformin + lifestyle group each having 173 patients. The primary objective will be to prevention of diabetes, its related complications and secondary objective of the trial will be to assess the safety of the therapy. We will also be evaluating the quality of life and will be utilizing nine internationally validated tools to evaluate such parameters. Results: The trial will be initiated after receiving all the formal approvals from local ethics committees and regulatory authorities. Its data will also be uploaded on clinicaltrials.gov and clinicaltrialresults.org websites once the trial is completed. Conclusion: A number of studies have looked at lifestyle and pharmacologic interventions in people with prediabetes to determine if progression to frank diabetes can be prevented and our trial would be the first of its kind in Pakistani people.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pancreatic Disorders & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPancreatic Disorders & Therapy
  • SubjectGastroenterology & Hepatology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Ishrat Kazmi”